Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7678735 | 0.87 | CCR5 (0.59) | CCR5 | |
| SCHEMBL7674733 | 0.85 | CCR5 (0.53) | CCR5 | |
| SCHEMBL5209742 | 0.84 | CCR5 (0.58) | CCR5 | |
| SCHEMBL5209740 | 0.83 | CCR5 (0.62) | CCR5 | |
| SCHEMBL7678218 | 0.81 | CCR5 (0.36) | CCR5 | |
| SCHEMBL5212440 | 0.81 | CCR5 (0.63) | CCR5 | |
| SCHEMBL7678464 | 0.81 | CCR5 (0.61) | CCR5 | |
| SCHEMBL5210250 | 0.80 | CCR5 (0.57) | CCR5 | |
| SCHEMBL5210244 | 0.78 | CCR5 (0.60) | CCR5 | |
| SCHEMBL7678529 | 0.77 | CCR5 (0.54) | CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116082328-B | Imidazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-20250169319-A1 | ORGANIC LIGHT-EMITTING DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-05-22 | — | — | US | disclosed |
| US-12207516-B2 | Organic light-emitting display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-01-21 | — | — | US | disclosed |
| CN-115974806-B | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-115835671-B | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-116891477-A | Indolocarbazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-10-17 | — | — | CN | disclosed |
| US-20230312458-A1 | COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND ALIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| CN-116156921-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116082328-A | Imidazole compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115974806-A | Heterocyclic compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115835671-A | Organic electroluminescent device | 长春海谱润斯科技股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| US-20220112996-A1 | JEWELRY AND GEM STONE LIGHTING SYSTEMS AND APPARATUSES AND METHOD MAKING AND USING SAME | ASHLEY PAUL (US) | 2022-04-14 | — | — | US | disclosed |
| US-6413947-B1 | Anilide derivative, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-02 | — | — | US | disclosed |
| US-6268354-B1 | Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-07-31 | — | — | US | disclosed |
| US-6172061-B1 | AIDS THERAPY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-01-09 | — | — | US | disclosed |
| US-6166006-A | Anilide derivative, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| EP-1040103-A1 | ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-1039899-A2 | PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE | Takeda Chemical Industries, Ltd. (JP) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999032100-A2 | PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-07-01 | — | — | WO | disclosed |
| WO-1999032468-A1 | ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312458-A1 | COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND ALIGHTING DEVICE | ARL1, AIPL1, ACVRL1 | CCR5 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.